secwatch.observer — SEC 8-K summary
======================================

Issuer:     IntelGenx Technologies Corp. (—)
CIK:        0001098880
Form:       8-K
Filed at:   2024-10-07T23:59:59+00:00
Accession:  0001062993-24-017455
Event type: m_and_a
Sentiment:  negative
Materiality: 0.95
Item codes: 2.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

IntelGenx Technologies completes acquisition by atai Life Sciences via credit bid; executives and board resign
--------------------------------------------------------------------------------

- On Sept 30, 2024, Superior Court of Québec approved a credit-bid acquisition by atai Life Sciences AG of all IntelGenx Corp. shares.
- Transaction closed Oct 2, 2024; atai used its senior secured debt as consideration; no cash or equity exchanged.
- Shareholders of IntelGenx Technologies will receive no payments; ResidualCo and New ParentCo expected to file for bankruptcy.
- CEO Dwight Gorham, CFO Andre Godin, and Corporate Secretary Ingrid Zerbe resigned on Oct 2, 2024.
- Entire board including Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/0001062993-24-017455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-24-017455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer